Stifel Nicolaus Starts Oncolytics Biotech (ONCY) at Buy
Tweet
Share
E-mailGet Alerts ONCY Hot Sheet
Price: $0.84 +2.44%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Stifel Nicolaus initiates coverage on Oncolytics Biotech (NASDAQ: ONCY) with a Buy. PT $6.00.
For an analyst ratings summary and ratings history on Oncolytics Biotech click here. For more ratings news on Oncolytics Biotech click here.
Shares of Oncolytics Biotech closed at $2.64 yesterday.
For an analyst ratings summary and ratings history on Oncolytics Biotech click here. For more ratings news on Oncolytics Biotech click here.
Shares of Oncolytics Biotech closed at $2.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oncolytics gets FDA feedback on colorectal cancer trial expansion
- Macquarie Starts Bursa Malaysia Bhd (BURSA:MK) at Outperform
- Macquarie Starts IJM Corp Bhd (IJM:MK) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
